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ABSTRACT

Ribosomal RNA Mutations That Inhibit the Activity of
Transfer-Messenger RNA on Stalled Ribosomes

Jacob N. Crandall
Department of Chemistry and Biochemistry
Master of Science

In eubacteria, stalled ribosomes are rescued by a conserved quality-control mechanism
involving transfer-messenger RNA (tmRNA) and its protein partner SmpB. Mimicking a tRNA,
tmRNA enters stalled ribosomes, adds Ala to the nascent polypeptide, and serves as a template to
encode a short peptide that tags the nascent protein for destruction. To further characterize the
tagging process, we developed two genetic selections that link tmRNA activity to cell death.
These negative selections can be used to identify inhibitors of tagging or to identify mutations in
key residues essential for ribosome rescue. Little is known about which ribosomal elements are
specifically required for tmRNA activity. Using these selections, we isolated ribosomal RNA
mutations that block the rescue of ribosomes stalled at rare Arg codons or at the inefficient
termination signal Pro-opal. We find that deletion of A1150 in the 16S rRNA blocks tagging
regardless of the stalling sequence, suggesting that it inhibits tmRNA activity directly. The
C889U mutation in 23S rRNA, however, lowers tagging levels at Pro-opal and rare Arg codons
but not at the 3'-end of an mRNA lacking a stop codon. We conclude that the C889U mutation
does not inhibit tmRNA activity per se but interferes with an upstream step intermediate between
stalling and tagging.

Keywords [rRNA, ribosome, helix 38, A-site finger, tmRNA, SmpB, trans-translation]
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CHAPTER 1 INTRODUCTION
Ribosomes synthesize proteins by polymerizing amino acids as directed by the
information in messenger RNA (mRNA). Transfer RNAs (tRNAs) charged with amino acids
bind mRNA codons within the ribosome. This binding of tRNAs positions the amino acids for
the ribosome to create a peptide bond between them. The ribosome then shifts the mRNA and
aminoacyl-tRNAs to allow the next appropriate aa-tRNA to enter and position its amino acid for
peptide bond formation. In this way, the ribosome is capable of producing long chains of amino
acids that are released into the cell and folded into active proteins.
Several ribosomes can be associated with a single mRNA at the same time. If the leading
ribosome on a mRNA becomes stalled, then the ribosomes following it also stall and the
ribosomal pool becomes depleted and can no longer support cellular life. To solve this problem,
bacteria have evolved a rescue mechanism termed trans-translation that releases the stranded
ribosomes and degrades the unproductive mRNA and unfinished proteins. The aim of our
research is to better understand how trans-translation factors interact with stalled ribosomes. Our
goal is to find ribosome mutants that inhibit trans-translational rescue of stalled ribosomes.

THE RIBOSOME
The Escherichia coli (E. coli) ribosome is comprised of two subunits. The large subunit
(50S) contains thirty-six proteins and a 2,904 nucleotide structured ribosomal RNA (23S rRNA)
and a 120 nucleotide structured ribosomal RNA (5S rRNA). The small subunit (30S) contains
twenty-one proteins and a 1,542 nucleotide structured ribosomal RNA (16S rRNA). Together
the large and small subunits form a functional 70S ribosome (Shown in Figure 1-1 is the
Thermus thermophilus 70S ribosome1 bound to mRNA and three tRNAs).
1

Figure 1-1. The ribosome

Figure 1-1 THE RIBOSOME
The 70S Ribosome of Thermus thermophilus1. Identified are the 23S rRNA in green, the 16S rRNA in
brown, tRNAs in blue and ribosomal proteins in grey. The 50S large subunit is made up of the 23S
rRNA and the protins within the green. The 30S small subunit is made up of the 16S rRNA and the
proteins associated with the brown (PDB# 2WRN – 30s and 2WRO – 50s).

THE TRANSLATION CYCLE
Protein synthesis on the 70S ribosome is carried out in three phases known as initiation,
elongation and termination. The ribosome cycles between these phases. Once a ribosome has
terminated protein synthesis on a particular mRNA, it will re-initiate on a new mRNA, elongate
the peptide, release it by termination, and re-initiate again (Figure 1-2).
Initiation begins when the 30S subunit associates with an mRNA template. This
interaction is facilitated by the presence of the Shine-Delgarno sequence (consensus AGGAGG)
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Figure 1-2. Ribosomal cycles

Figure 1-2. RIBOSOMAL CYCLES
(1) The 70S ribosome following initiation, with mRNA and fMet-tRNA in the P site. (2) EF-Tu (orange)
delivers aminoacyl-tRNA to the A site. (3) and (4) Methionine is then transferred to the A-site aatRNA. (5) Translocation by EF-G (purple box) shifts the A-site peptidyl-tRNA into the P site and the
elongation cycle starts over at 2 until the peptide is fully elongated and the stop codon is located in the A
site. (6) With the stop codon in the A site, a release factor (red) enters and hydrolyzes the peptidyl-tRNA
linkage, releasing the peptide. (7) RF3 is recruited to release the release factor. (8) RRF (green) and
EF-G then dissociates the subunits and the cycle begins again with 1.
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on the mRNA and a complementary sequence on the 16S rRNA. This binding interaction not
only brings the mRNA to the small 30S subunit, but also helps select the reading frame. Three
proteins known as initiation factors 1, 2 and 3 (IF1, IF2, IF3) bind the 30S-mRNA complex. IF2
bound by guanosine triphosphate (IF2-GTP) associates formyl-methionine-initiator tRNA (fMettRNA) with the AUG codon. Once this pairing occurs, IF3 is released. When IF3 is no longer
bound, the 50S subunit binds, activating GTP hydrolysis by IF2, releasing IF1 and IF2. The
binding of the 50S subunit signals completion of initiation and the beginning of elongation
(Figure 1- 2).
Elongation proceeds with the help of two elongation factor proteins, elongation factor-Tu
(EF-Tu) and elongation factor-G (EF-G). EF-Tu binds aminoacyl-tRNAs and escorts them into
the ribosome (Figure 1-2, Step 2). Within the ribosome are three tRNA binding sites know as
the A, P, and E sites. Incoming tRNAs first bind the A (aminoacyl-tRNA or acceptor) site,
which selects for tRNAs that correctly pair with a given mRNA codon. During the first
elongation step, fMet-tRNA is already positioned in the P (peptidyl) site. Once an aa-tRNA is
delivered to the ribosomal A site by EF-Tu, a peptide bond forms between fMet and the A-site
amino acid. The dipeptide is now attached to the A-site tRNA (Figure 1-2, Step 4). In a process
known as translocation, EF-G shifts the mRNA, free tRNA and peptidyl tRNA three nucleotides
(Figure 1-2, Steps 4-5). The deacylated tRNA moves to the E (exit) site where it is ejected. The
peptidyl-tRNA occupies the P site. With an empty A site, the next aa-tRNA binds and the cycle
of elongation continues until a stop codon is reached (Figure 1-2, Step 6).
Since tRNAs do not recognize the stop codons UAA, UAG or UGA, elongation is halted
and either release factor 1 or 2 (RF1 or RF2) binds the stop codon and frees the peptide from the
peptidyl-tRNA. Following the release of the peptide, release factor 3 (RF3) helps release the
4

Figure 1-3. Stalling and rescue

Figure 1-3. STALLING AND RESCUE
In the first column are shown three representative types of stalling: Non-stop mRNA, rare-arg , and
pro-stop. Types of rescue are represented in the second column: Trans-translation, -1 frameshifting, +1
frameshifting and readthrough. Of these four rescue methods nonstop mRNAs can only be rescued by
trans-translation. However, rare-arg and pro-stop stalling can be rescued by readthrough and
frameshifitng unless induced into a irreversible stalling non-stop mRNA. The frameshifting and
readthrough situations are represented by rescue of pro-stop stalling.
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bound release factors. The ribosomal subunits are then pried apart by ribosome recycling factor
(RRF) and EF-G, releasing free subunits, the mRNA and tRNAs (Figure 1-2). Once the subunits
dissociate they are free to initiate another round of translation.

STALLING AND RESCUE
Sometimes ribosomes encounter mRNAs that cause them to stall during protein
synthesis. Ribosome stalling events can either be reversible (the ribosome pauses and then
resumes translation) or irreversible (the ribosome stalls completely and cannot resume
translation).
Irreversible stalling occurs when translation has reached the 3' end of the mRNA without
having encountered a stop codon, and there is no message to be decoded in the A site. mRNA
transcripts lacking a stop codon are referred to as non-stop mRNAs. In the bacterial cell,
mRNAs are degraded from the 3' end relatively quickly; the average half-life of an mRNA in E.
coli is ~6 minutes4, 5. This 3' degradation can create non-stop mRNAs if exonucleases that with
the ribosome after removing the stop codon. The abundance of non-stop mRNAs, and the
resulting irreversibly stalled ribosomes, poses a threat to cell viability. To rescue irreversibly
stalled ribosomes, the cell uses trans-translation (Figure 1-3). Trans-translation keeps the cell
healthy by recycling stalled ribosomes, adding a new message to the A site and continuing
translation to a stop codon. Ribonucleases and proteases are then recruited to destroy the
aberrant mRNA and peptide.

6

Reversible stalling occurs for many reasons, one of which is strings of rare codons
translated by rare tRNAs. Rare codons are those codons that are rarely found in protein coding
genes compared to other codons within the genome of a given species. Since the cognate tRNAs
that recognize rare codons are also scarce, overexpressing the gene will deplete all the available
tRNAs that decode the rare codon, leaving the ribosome with an empty A site (Figure 1-3). An
example in E. coli is the rare arginine codon AGG. AGG represents only 0.2% of all the codons
in protein codin genes in E. coli. In contrast the arginine codon CGC appears 2.2% of the time.
When mRNAs containing AGG codons are overexpressed, the cell has insufficient tRNA to
decode the A site codon and the ribosome becomes stalled. However, because there is mRNA
message extending beyond the stalling site, translation can be rescued by the arrival of the proper
tRNA, by misreading of another tRNA (readthrough), or by frameshifting6 (Figure 1-3).
Another example of reversible stalling is the inhibition of the termination reaction by
proteins ending in proline. If peptidyl prolyl-tRNA is in the ribosomal P site and a stop codon is
in the A site, as is the case at the sequence Pro-stop, the function of the release factor is inhibited
(Figure 1-3). The strength of the stalling event is dependent upon the upstream (-2) amino acid.
Sequences Glu, Asp, Ile, Val, or Pro-Pro-stop have the strongest stalling phenotypes7. The
mechanism of stalling is not clear, but evidence suggests that the proline residue slows down its
own release. This is supported by experimentation with RF bound at the A-site of the ribosome
and peptidyl prolyl-tRNA in the P site. These experiments showed that catalysis of the nascent
peptide from the prolyl-tRNA is inhibited to the point that it affects cell growth8. Further studies
using the antibiotic puromycin, which reacts with and releases nacent peptides, demonstrated that
peptide release of a peptidyl prolyl-tRNA was slower than release with any other C-terminal
amino acid9. Furthermore, a recent cryo-EM structure which contained a peptidyl prolyl-tRNA
7

in the P site and a stop codon in the A site showed the proline amino acid making contacts with
the peptidyl-transferase center (PTC) of the ribosome, resulting in an inactive conformation10.
Although trans-translation was first discovered because it rescues ribosomes on non-stop
mRNAs, ribosomes stalled at rare codons or at termination can also be rescued by transtranslation. However, this is only possible if the transcript is converted into a non-stop mRNA
by either endonucleolytic RNA digestion at the A site of the ribosome or by exonucleolytic RNA
digestion of the 3' end of the mRNA11. An example of this occurs during E. coli starvation. At
starvation, E. coli elicit the stringent response to slow down protein production by generating
non-stop mRNAs using the bacterial toxin RelE, a known endoribonuclease12, 13. RelE cleaves
mRNA at the A site of the ribosome, generating non-stop mRNAs and inducing irreversibly
stalled ribosomes14. These ribosomes are then rescued by trans-translation.

TRANS-TRANSLATION
Trans-translation rescues irreversibly stalled ribosomes by adding new message to the A
site of the ribosome so that translation can continue to a stop codon (Figure 1-3). Transtranslation has two main players: transfer-messenger RNA (tmRNA) and small protein B
(SmpB). tmRNA acts both as a tRNA and an mRNA to rescue stalled ribosomes. This is first
done by tmRNA-SmpB mimicking a tRNA and entering the empty A site of the ribosome
(Figure 1-4). Since tmRNA is aminoacylated by alanyl-tRNA synthetase, it can add Ala to the
growing polypeptide chain. The SmpB-tmRNA complex is then translocated to the P site, and
the open reading frame of tmRNA is placed in the decoding center of the ribosome to be
translated. Translation of the tmRNA open reading frame continues to a stop codon which
releases the peptide and recycles the ribosome. The amino acid sequence encoded by tmRNA
8

Figure 1-4. Trans-translation

Figure 1-4 TRANS-TRANSLATION
When the ribosome stalls (1) the A-site mRNA is removed from the ribosome and the SmpB-tmRNA
complex enters (2). The alanine of tmRNA is now positioned for peptidyl transfer (3). After peptidyl
transfer and translocation, the open reading frame of tmRNA is positioned in the A site for elongation
to resume (4). After termination at a stop codon on the tmRNA template, the ribosomal subunits are
recycled and the tagged protein is degraded by proteases (5).

and added to the nascent peptide signals it to be destroyed by proteases. It has also been
proposed that ribonucleases that associate with the tmRNA complex complex target and degrade
the released mRNA to ensure it no longer can be translated15. It is because of this that tmRNA is
conserved in all eubacterial genomes and has even been shown to be essential for a number of
different bacterial species16-19.
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Figure 1-5. Secondary structure of tmRNA

Figure 1-5. SECONDARY STRUCTURE OF TMRNA
The secondary structure of tmRNA with pseudoknots identified as PK1-PK4. The TLD is labeled at the
5‘ and 3‘ helix with the CCA at the very 3‘ end. Canonical base pairs are identified by dashes and noncanonical base pairs are identified by dots.
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TMRNA AND

SMPB STRUCTURE

tmRNA in E. coli is a 363 nucleotide RNA with four pseudoknots (PK) that form most of
its structure (Figure 1-5). These pseudoknots convey structural stability. Although PK 2-4 can
be deleted with little loss of function, PK1 needs a thermodynamically stable structure to
maintain trans-translational activity20. Connecting pseudoknots 1 and 2 is the open reading
frame of tmRNA that encodes the degradation tag ANDENYALAA(Stop). The tRNA-like
domain (TLD) is formed by the 5' and 3' ends through loops and helices that interact with SmpB
(Figure 1-5 and Figure 1-6). SmpB is 160 amino acids long and folds into an antiparallel β-barrel
and three helices. A 30 amino acid long C-terminal tail comes out of the protein and due to its
lack of structure, cannot be seen by cryo-EM or crystal structures.
Figure 1-6. tmRNA-SmpB complex molecular mimicry

Figure 1-6. TMRNA-SMPB COMPLEX MOLECULAR MIMICRY
SmpB (light blue) and the TLD of tmRNA (dark blue) structurally mimic tRNAs. The structures shown
are a yeast tRNAPhe in red and a T. Thermophilus tRNAser in green3. Reprinted with permission by
PNAS.

Functional activity of tmRNA is known to be linked to the cellular expression and
association of SmpB18. Using its beta barrel core, SmpB binds tmRNA at its TLD with high
affinity (Figure 1-6). This interaction between SmpB and tmRNA protect both molecules from
11

being degraded within the cell21, 22. The binding of tmRNA by SmpB creates a structural mimic
of a cellular tRNA3 (Figure 1-6). This tRNA conformation is essential for tmRNA
aminoacylation by alanyl-tRNA synthetase, acceptance into the A-site of the ribosome, and
peptide transfer3, 18, 21-24.

THE RIBOSOME AND T RANS-TRANSLATION
The goal of the research presented in this thesis is to find ribosomal RNA mutations that
inhibit tmRNA function. Ideally, these mutations would specifically inhibit trans-translation and
not canonical translation. Regions of the rRNA that are likely essential for tmRNA function are
the peptidyl-transferase center, decoding center, or GTPase center of the ribosome. These
regions play critical roles in canonical translation as well.
For example, the 16S bases A1492, A1493 and G530 in the decoding center (the 30S A
site) undergo conformational changes upon correct pairing of the mRNA codon to the tRNA
anticodon25, 26. These conformational changes are vital to tRNA selection and translational
fidelity. It is also believed that the SmpB-tmRNA complex is accepted into the A site by SmpB
interacting directly with these same bases at the decoding center. This is supported by cryo-EM
data orients SmpB to the decoding center of the ribosome and biochemical data that suggest that
SmpB interacts directly with A1492, A1493 and G53027, 28. SmpB tail mutations and truncations
abolish the ability of tmRNA to transfer Ala to the nascent peptide, though they have no effect
on tmRNA binding to the ribosome29. Therefore, mutations to the decoding center might
decrease the translation of the tmRNA tag by rejecting the SmpB-tmRNA complex from being
accepted into the A site. To the extent that tmRNA function relies on these same conserved
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nucleotides, however, mutating them might also inhibit normal tRNA acceptance into the A site
and overall protein production.
Another way that ribosomal mutations could inhibit trans-translation would be to reduce
stalling. This could be accomplished at stalling sequences like Pro-stop by rRNA mutations that
increased termination at C-terminal Pro residues. In the case of stalling at strings of rare Arg
codons, mutations could increase the miscoding frequency. If readthrough or frameshifting rates
increase in a given rRNA mutant, stalling could be reduced and the ribosomes would no longer
need rescue by tmRNA.
Since the SmpB-tmRNA complex makes extensive contacts with the ribosomal rRNA
and proteins27, 30 it is likely that ribosomal mutations could also decrease the binding affinity of
tmRNA and or SmpB. This could prevent tmRNA recruitment to the A site. It could also
prevent translocation of tmRNA to the P site. It has been shown that SmpB has an affinity for
the A and P sites of the ribosome even without tmRNA31. As discussed above, SmpB plays an
important role in the acceptance of the SmpB-tmRNA complex into the A site of the ribosome.
Its highest affinity binding site, however, is the 30S P site, and so SmpB may also play a critical
role for tmRNA translocation to the P site. This is most likely done by a different mechanism
than translocation of tRNAs since they are attached to mRNA which is in contact with the P site.
In the case of trans-translation SmpB contacts the P site. Translocation of tRNAs employs
specific residues of the 16S rRNA32. Because these bases are most likely unimportant to
translocation of the SmpB-tmRNA complex, then 16S mutations that did not include these bases
could inhibit translocation of SmpB and tmRNA without affecting translocation of tRNA
important to protein production.
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A final way in which inhibition of trans-translation might be effected would be
interfering with placement of the first codon of the tmRNA open reading frame in the A site.
The role of tmRNA-ribosomal interactions in resume codon placement is minimal. Mapping of
the interactions between tmRNA in the ribosomal P site showed few contacts at the TLD and
PK-133. Translation resumes at the GCA Ala codon (underlined) in the sequence U85AGUCGCA
in tmRNA. For instance the U85A mutation causes the ribosome to resume in the -1 frame on
the C89GC codon rather than on the G90CA resume codon34. Likewise the A86C mutant resumes
translation exclusively in the +1 frame placing C91AA in the A site34, 35. SmpB is thought to be
the element of the tmRNA-SmpB-ribosomal complex that interacts with the tmRNA upstream
nucleotides. This is supported by the finding that several SmpB mutants restore translation in the
proper frame on A86C tmRNA36 and the finding that SmpB protects these nucleotides from
reacting with chemical probes in vitro37, 38.
Mapping of SmpB with the ribosome showed several interactions with both the A and P
sites of the 16S and 23S rRNA31. These tight interactions explain why SmpB has such a high
affinity for the ribosomal P site in vitro even without tmRNA39-41. Because SmpB is essential to
the placement of the open reading frame of tmRNA it must associate with the ribosomal P site
and have correct positioning for functional rescue to take place.

The ribosomal P-site rRNA is

therefore a potential target for ribosomal mutations that could inhibit translation of the tmRNA
tag without affecting canonical translation.
The questions remain, what mutations of the ribosome could decrease stalling or inhibit
the SmpB-tmRNA complex from interacting with the ribosome and carrying out efficient transtranslation and not effect translation? Since many mutations could likely affect both, we
approached this question by randomization of the rRNA within the ribosomal subunits and a
14

selection against tmRNA tagging. This approach allows us to test many rRNA nucleotides for
their ability to reduce trans-translation but not translation all at once.
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CHAPTER 2 RRNA MUTATIONS THAT INHIBIT TRANSFER-MESSENGER RNA ACTIVITY ON
STALLED RIBOSOMES
This chapter is modified from the published article: Crandall, J.; Rodriguez-Lopez, M.; Pfeiffer,
M.; Mortensen, B.; Buskirk, A., rRNA mutations that inhibit transfer-messenger RNA activity on
stalled ribosomes. J Bacteriol 2010, 192, (2), 553-9.

INTRODUCTION

Defects in protein synthesis threaten cell viability in eubacteria. mRNA transcripts
lacking stop codons (non-stop mRNAs) arise from premature termination of transcription and
from mRNA decay by 3’-5’ exonucleases. Since release factors cannot be recruited to non-stop
mRNAs, ribosomes stall at the 3’-end and trap additional ribosomes upstream. In Escherichia
coli, roughly 1 in every 250 translation reactions leads to ribosome stalling, so that if they were
not rescued and recycled, all the ribosomes would be stalled in a single generation42.
A highly-conserved quality control system shields eubacterial cells from the negative
effects of ribosome stalling (for a review, see19). All known eubacterial genomes contain genes
encoding transfer-messenger RNA (tmRNA) and its protein partner SmpB43. As implied by its
name, tmRNA has two functions. First, tmRNA mimics a transfer RNA: it is aminoacylated
with alanine, enters the A site of stalled ribosomes together with SmpB, and adds Ala to the
nascent peptide chain. tmRNA then serves as an mRNA template, encoding a short peptide tag
that is recognized by cellular proteases44. After this tag is translated, the ribosome is released at
a stop codon within tmRNA and the aborted protein is degraded. Because the ribosome
translates a protein from two RNA templates, this tagging process is known as trans-translation.
In addition to rescuing ribosomes on non-stop mRNAs, tmRNA can also act on
ribosomes stalled on intact transcripts. Stalling can occur during elongation at clusters of rare
16

codons, such as the Arg codons AGA, AGG, and CGA45-47. The ribosome pauses on rare codons
because the cognate tRNAs are in low abundance and therefore bind and react slowly. Stalling
can also occur during translational termination when release of the nascent polypeptide is
inefficient. For example, tmRNA tags the full-length YbeL protein in E. coli; the C-terminal
Glu-Pro sequence in YbeL inhibits release factor activity7. When combined with an inefficient
opal stop codon (UGA), a C-terminal Pro residue can lead to levels of stalling so high that 40%
of the full-length protein is tagged by tmRNA7.
We have taken a genetic approach to the study of ribosome stalling and rescue,
developing genetic selections for and against tmRNA function. While tmRNA is essential in
some bacterial species16, deletion of the tmRNA gene ssrA in E. coli yields only minor
phenotypic changes24. We previously reported a KanR-based selection that ties the life of the
cell to tmRNA function20. This selection has proved valuable in studying mutants of tmRNA
and SmpB to understand how the ribosome resumes translation on tmRNA20, 36. Here we report
two novel selections in which tmRNA function leads to cell death. To our knowledge, these are
the first genetic selections developed against tmRNA activity. We apply these negative
selections to identify ribosomal RNA mutations that inhibit tagging at two different stalling
sequences. Our goal is to understand which ribosomal elements are specifically required for
trans-translation and the role of the ribosome in the rescue process.

MATERIALS AND METHODS
Plasmid construction—The bar-R selection plasmid was generated by amplifying the barnase
gene with PCR using the primers 3483 CATATGGCTAGCCAGGTTATCAACACGTTTGAC
and 3600 GAGCTCGAATTCGTCACCTTGTTTTGTAAATCAGCCAGTCGC. The PCR
17

product was cloned downstream of the araBAD promoter in pBAD-GFP using the NheI and
EcoRI restriction sites. The bar-P selection was cloned in a similar manner, except that barnase
was amplified with primer 3483 and 3722
GAGCTCGAATTCGTCAGGGTGAGTAAAGAATCCGGTCTG. The tmRNA-B1 expression
plasmid was generated by amplifying the pKW11 plasmid48 by inverse PCR using the primers
3486 GATCCGCTAATAAAGGATTCTTGGTCCTCTCTCCCTAGCCTCC and 3487
TTGGTAAAGGTCTGATAATGGTCGACTATTTTTTGCGGCTTTTTAC. Following
phosphorylation with polynucleotide kinase, the blunt ends of the PCR product were ligated
together. The tmRNA-B2 plasmid was cloned in a similar manner with primer 3486 and 3721
TTGGTAAAGGTCTGATAATGGTCTGTTGTTTTGTAAATCAGCCAGTCGACTATTTTTT
GCGGCTTTTTA.
To create the ptRNA-BT selection plasmids, the tetR and ssrA genes were amplified from
the tmRNA-B1 or B2 plasmids above with the following primers
TTCGCCTCCGGATTGACAGCTTATCTTCGATTAGCTTTAATGCGGTAGTTTATC and
ACTCACTCCGGAAAATAAATCCTGGTGTCCCTG and the PCR product was inserted into
the BspEI site in ptRNA-6749. Into the HindIII site of the resulting plasmids we inserted the
araC gene and bar-R or bar-P expression cassettes amplified with the primers
ACCAGCAAGCTTTTCACCGTCATCACCGAAAC and
TAAACACAAGCTTCGCAGAAAGGCCC.
The maltose binding protein (MBP) vectors are derivatives of pMAL-C2G (New England
Biolabs) in which the lacI coding sequence was deleted and MBP is expressed constitutively
from the lacI promoter. We combined this MBP expression cassette with a pCDF origin and
TetR marker, creating pCDF-MBP. To add stalling sequences, the 3’-end of the MBP gene was
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amplified with the primer TAACAAAGATCTGCTGCCGAACC and either
GGAAGCCTGCAGTCAGGGTGAAGTCTGCGCGTCTTTCAGGG (Ser-Pro-opal) or
GGAAGCCTGCAGTCACCTCCTCCTCCTCCTCCTCCTCCTAGTCTGCGCGTCTTTCAGG
GC (eight rare AGG Arg codons) or
GGAAGCCTGCAGTCACCTAGTCTGCGCCTCTTTCAGGGC (Arg-opal) or
ACAAGGCTGCAGAAAAAAGCCCGCTCATTAGGCGGGCTGCGGTCTGCGCGTCTTTC
AGGG (non-stop, adding the trpA terminator). These PCR products were digested with BglII
and PstI and ligated into the expression vector.
The GST recoding vectors were created by inverse PCR of pCDF-MBP with the primers
CCCTACTGCAGGCAAGCTTGGCACTG and
TTGCTAGGTACCATTCACCACCCTGAATTGACTC to add PstI and KpnI sites. GST was
amplified from pGEX-3 (GE Healthcare) using the forward primer
TTGCTAGGTACCATGTCCCCTATACTAGGTTATTG and one of the following reverse
primers:
GGAAGCCTGCAGTTATTACTTATCGTCATCGTCCTTATAGTCTTGTCAGGGAGAGAG
GATCCCACGACC (readthrough),
GGAAGCCTGCAGTTATTACTTATCGTCATCGTCCTTATAGTCTTGGTCAGGGAGAGA
GGATCCCACGACC (plus one frameshifting), or
GGAAGCCTGCAGTTATTACTTATCGTCATCGTCCTTATAGTCTTGGGTCAGGGAGAG
AGGATCCCACGACC (minus one frameshifting). The GST amplicons were digested and
ligated into the PstI and KpnI sites. araC and the araBAD promoter were amplified with the
primers AGATCCACTAGTACTGACAGATCTTCGCTACGTGACTGGGTC and
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GGACATGGTACCCATATGTATATCTCCTTCTTAAAGTTAAAC and inserted between
SpeI and KpnI sites upstream of GST to drive its expression.
Table 2-1. Bacterial strains and plasmids.
Table 2-1. Bacterial strains and plasmids.
Material
SQ171

Genotype or Description
ΔrrnG ΔrrnA ΔrrnD ΔrrnE ΔrrnH ΔrrnB ΔrrnC recA – ptRNA67 pKK3535

X90
ssrA::cat
pbar-R

F’ lacIq lac’ pro’ / ara Δ(lac-pro) nalA argE(am) rifr thi-1 ssr::cat

pbar-P
ptmRNAB1
ptmRNAB2
ptRNA67
ptRNABT1
ptRNABT2
pTS-rrnC
pCDFMBP
pCDFGST
rRNA
libraries

Refernece
49 and
Squires
44

pBR322 derivative, expresses truncated barnase (Δ10) from araBAD
promoter, with rare Arg-opal at the C-terminus
pBR322 derivative, expresses truncated barnase (Δ18) from araBAD
promoter, with Pro-opal at the C-terminus
Tetr and p15A origin, expresses tmRNA with 10 residue barnase tag

This study

Tetr and p15A origin, expresses tmRNA with 18 residue barnase tag

This study

Spcr p15A origin, expresses tRNAs missing from the genome of SQ171

49

r

This study
This study

Derivative of ptRNA67, Tet and expressing the bar-R and tmRNA-B1

This study

Derivative of ptRNA67, Tetr and expressing the bar-P and tmRNA-B2

This study

Expresses wild-type rRNA; temperature-sensitive SC101 origin

This study

r

Tet and CDF origin, expresses MBP constitutively with various stalling
sequences at the C-terminus
Tetr and CDF origin, expresses GST from araBAD promoter with Proopal followed by the FLAG epitope in various frames
Derivatives of pLK45 with mutant rRNA cloned in targeted segments of
either the 16S or 23S genes

This study
This study
50

Selection—rRNA libraries generously provided by Alexander Mankin50 were amplified
and introduced into the SQ171 strain carrying either the ptRNA-BT1 or -BT2 selection plasmids.
The cells were rescued for 2 h at 30 °C in 2xYT with 0.2% glucose then added to 400 mL of
2xYT, 0.2% glucose, and 100 μg/mL ampicillin. The culture was grown 20 h at 37 °C to allow
for loss of the wild-type ribosome plasmid, ribosome turnover, and the synthesis of the new
mutant ribosomes. The culture was then plated onto media containing ampicillin and 2%
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arabinose to induce barnase expression. Plasmid DNA was extracted from the pool of surviving
cells and resubjected to the selection procedure.
Immunoblots—Tagging of the MBP protein was assayed by immunoblot as described 35
except that expression of MBP was constitutive, not induced with IPTG. Analysis of recoding
events on GST was performed similarly, except that expression was induced with 2% arabinose
for 2 h and readthrough or frameshifting was detected with a monoclonal anti-FLAG antibody
(Sigma).

RESULTS
DEVELOPMENT OF A SELECTION AGAINST TM RNA TAGGING AT RARE ARG CODONS
To isolate ribosomal RNA mutations that prevent tmRNA function, we created a genetic
selection that links tagging to cell death. We altered tmRNA so that instead of tagging proteins
for proteolysis, it completes the synthesis of a toxic protein. Barnase is a 110-residue
ribonuclease that is highly toxic; it has been used previously in negative selections with excellent
results51, 52. A catalytic base, His102, is required for activity53. We removed this critical residue
by deleting the last 10 amino acids in the barnase protein. This truncated protein is harmless.
We created a tmRNA mutant (tmRNA-B1) that rescues ribosomes stalled during barnase
synthesis and completes the protein by encoding the last ten amino acids, DHYQTFTKIR
(Figure 2-1A). To induce stalling at the proper site, we mutated Thr100 to the rare Arg codon
AGG, followed by the opal stop codon UGA, yielding the bar-R construct. As shown
previously, inefficient release at the opal stop codon traps the cognate Arg-tRNA, leading to
further depletion of this rare tRNA and stalling at this Arg codon46. Upon rescue, the nascent
barnase protein is transferred to Ala-tmRNA and the ribosome switches to the tmRNA-B1 open
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Figure 2-1. Genetic selection against trans-translation

Figure 2-1. GENETIC SELECTION AGAINST TRANS-TRANSLATION
tmRNA directs the completion of the toxic ribonuclease barnase, leading to cell death. A) Transcription
of a truncated barnase gene ending in Arg-opal is driven by the arabinose-inducible araBAD promoter.
Ribosomes stall at the 3’-end of barnase at the rare Arg codon AGG due to sequestration of the rare
cognate tRNA. tmRNA with a modified tag sequence (tmRNA-B1) rescues the stalled ribosomes and
encodes the missing residues, after which full-length barnase kills the cell. Expression of the barnase
construct (bar-R) is only toxic when co-expressed with tmRNA-B1 and induced with 2% arabinose
(bottom). B) A second, similar selection in which stalling is induced by inefficient termination at a Proopal sequence at a different site in the barnase protein, which is then tagged by tmRNA-B2.

reading frame, completing the toxic protein. Barnase synthesized through the tagging process
contains only one mutation, Thr100Ala.
To validate this negative selection, we transformed a strain lacking tmRNA (X90
ssrA::cat) with a plasmid encoding bar-R driven by the arabinose-inducible araBAD promoter.
Plating of serial dilutions reveals that bar-R alone is non-toxic, as cells grow equally well on
glucose or arabinose (Figure 2-1A). In contrast, fewer than 1 in 104 cells containing both bar-R
and tmRNA-B1 survive on media containing arabinose (Figure 2-1A). These results show that
stalling and rescue of the barnase protein by tmRNA-B1 leads to cell death.
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DEVELOPMENT OF A SELECTION AGAINST TM RNA TAGGING AT PRO -OPAL
We also created a second barnase selection in which stalling occurs at Pro-opal rather
than Arg-opal. We anticipated that such a selection might identify mutants that inhibit stalling,
perhaps by suppressing the inefficient termination at C-terminal Pro residues7. Like the bar-R
selection described above, the bar-P selection relies on stalling at a truncated barnase gene and
rescue by a modified tmRNA to complete barnase and kill the cell (Figure 2-1B). We truncated
barnase by 18 amino acids by mutating Ser92 to Pro and introducing an opal stop codon at codon
93. The tmRNA template was altered to encode the missing barnase residues
DWLIYKTTDHYQTFTKIR (hereafter referred to as tmRNA-B2). Two mutations occur in the
final barnase protein: the Ser92Pro mutation and insertion of Ala between residues 92 and 93.
As these changes occur in a surface-exposed loop between two -strands54, this scar was not
anticipated to affect barnase function. Analysis of cells containing bar-P and tmRNA-B2
confirms the toxicity upon induction with arabinose, while bar-P alone is non-toxic. Fewer than
1 in 106 cells survive the bar-P selection on arabinose (Figure 2-1B).

SELECTION FOR 16S RRNA MUTANTS THAT INHIBIT TAGGING AT ARG-OPAL
The isolation of ribosome mutants that prevent tagging requires that each cell contain
only one rRNA operon, since wild-type ribosomes would tag barnase and kill the cell. Squires
and co-workers have generated E. coli strains in which each of the seven ribosomal RNA
operons is genetically deleted (SQ171 recA–) (49 and Selwyn Quan and Cathy Squires, personal
communication). We introduced two plasmids into the SQ171 strain to adapt it to our selection.
ptRNA-BT1 encodes tRNAs missing from the genome as well as the selection genes bar-R and
tmRNA-B1. The second plasmid, pTS-rrnC, expresses the rrnC ribosomal RNA operon and has
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a temperature-sensitive pSC101 origin. This plasmid is rapidly lost at 37 °C if the cells have
another source of rRNA, allowing us to exchange it for plasmids encoding mutant rRNA
operons. This approach ensures that mutant ribosomes function efficiently in all stages of
translation because they are solely responsible for protein synthesis. In effect, this is a built-in
positive selection for ribosome function added to the negative selection against stalling and
tagging.
To isolate mutants that inhibit tagging at Arg-opal, we screened a library of 104 - 105
mutant 16S rRNA genes50 in the SQ171 ptRNA-BT1 selection strain. The small subunit RNA
was chosen because we were initially interested in how tmRNA and SmpB interact with the
decoding center upon entering the A site of stalled ribosomes. After three rounds of selection
and enrichment, nearly all of the transformed cells survived on selective media. Sequencing of
the 16S rRNA in surviving colonies revealed three clones containing one mutation each: the
point mutant A1150G or deletion of A1150 or U1123. It is impossible to tell which nucleotide in
1150-1152 (AAA) is deleted; the same is true of 1121-1123 (UUU). Since these two sequences
pair together, we believe that all three mutations have the same structural consequence (see
Discussion). The activity of all three clones was confirmed by retransformation and testing of
single colonies in the barnase selection. Serial dilutions demonstrate robust survival of the
representative A1150Δ mutant upon induction of barnase with arabinose (Figure 2-2). Growth
curves reveal that the A1150Δ mutation causes a mild growth defect (doubling time of 65 min
compared to the wild-type 59 min), consistent with a general defect in translation.
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23S RRNA MUTANTS THAT INHIBIT TAGGING PRO-OPAL
We also isolated ribosomal RNA mutations that inhibit tagging at Pro-opal. Initially we
hoped to find rRNA mutants that would restore efficient termination. We therefore chose the
23S rRNA for mutagenesis because it contains the peptidyl-transferase center, the site where the
peptide is hydrolyzed from tRNA during the termination reaction. We first tested 23S mutants in
the bar-P selection that were reported in the literature to inhibit stalling on the peptides SecM
and TnaC. These mutants include A2058G, U2609C, U754A, and Ains75155, 56. None of them
showed an increase in survival compared to wild-type rRNA (data not shown). We therefore set
out to identify mutants from random rRNA libraries. A library of 104 - 105 23S mutants50 was
introduced into the SQ171 ptRNA-BT2 selection strain. After two rounds of enrichment, nearly
all the transformants on the selection plates survived. Sequencing of the 23S rRNA genes
revealed two clones, one with the single C889U mutation and the other with two mutations,
C889U and U846C. The activity of these mutants was verified by retransformation and testing
of single colonies in the barnase selection (for C889U, see Figure 2-2).
The C889U and U846C mutations are found in helix 38, known as the A-site finger or
ASF57. This helix forms intersubunit bridge B1a, crossing over the A site and contacting the S13
protein in the small subunit58. The C889U mutation is found at the tip of the finger in the loop
that contacts S13. Perhaps this mutation exerts its effect by disrupting bridge B1a. We
tested this hypothesis by performing the bar-P selection on cells containing a 22 nt deletion in
helix 38 (H38Δ22), effectively destroying the B1a interaction59. No increase in survival was
observed, indicating that disruption of the B1a interaction is insufficient to prevent tagging
(Figure 2-2).
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Figure 2-2. Ribosomal RNA mutants that survive the barnase selection

Figure 2-2. RIBOSOMAL RNA MUTANTS THAT SURVIVE THE BARNASE SELECTION
SQ171 cells expressing a single rRNA operon were plated on media containing either 2% arabinose to
induce barnase expression or 0.2% glucose to repress it. Wild-type rRNA and a 16S mutant lacking
A1150 were characterized in the bar-R selection (top). Two helix 38 mutants were compared to wildtype rRNA in the bar-P selection (bottom). 10-fold serial dilutions of the culture are shown from left to
right.

Previous studies have shown a slight growth defect from truncating helix 38 and
disrupting B1a59-61. We measured growth rates for SQ171 cells expressing either wild-type or
C889U mutant rRNA and found them to be identical (with a 59 min doubling time). Since there
is only one ribosomal RNA operon in these cells, the mutant ribosomes must be capable of
performing essential functions in translation as well as wild-type ribosomal RNAs.

THE SELECTED MUTATIONS INHIBIT TAGGING AT THEIR RESPECTIVE STALLING SEQUENCES
To confirm that the selected rRNA mutants rescue cells in the barnase selection by
reducing the amount of tagged protein produced, we performed immunoblots to measure tagging
levels directly. To test the 16S A1150Δ mutant isolated in the bar-R selection, we expressed the
full-length maltose-binding protein (MBP) with a rare Arg-opal sequence at the C-terminus to
induce stalling. We altered the tmRNA template to encode the sequence ANDHHHHHHD so
that tagging can be detected by anti-His6 antibodies35. These changes in the tag also prevent
rapid proteolysis of the tagged product48. Analysis of the Arg-opal construct in SQ171 revealed
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that tagging is reduced nearly three-fold in the mutant strain compared to wild-type (Figure 2-3,
lanes 5 and 6).
Similarly, we tested whether our selected 23S mutants inhibit tagging using an MBP
construct ending in Pro-opal. Using anti-His6 antibodies to visualize the addition of the tmRNA
tag, we see a four-fold decrease in tagging in the C889U and double mutant strains compared to
wild-type (Figure 2-3, lanes 1-3). No reduction of tagging was seen in the H38Δ22 mutant (lane
4), as predicted by its inability to survive the bar-P selection. These immunoblot data show that
both the A1150Δ and C889U mutations reduce tagging levels at their stalling sequences, Argopal and Pro-opal, respectively, confirming the genetic results above.

Figure 2-3. Analysis of tagging levels in mutant strains

Figure 2-3. ANALYSIS OF TAGGING LEVELS IN MUTANT STRAINS
The maltose binding protein (MBP) was expressed with various stalling sequences at the C-terminus:
Pro-opal, Arg-opal, a string of eight rare Arg codons (AGG), or a non-stop MBP construct containing
the trpA transcriptional terminator. Tagging of MBP by a modified tmRNA encoding a His 6 tag was
detected by anti-His6 antibodies. Anti-MBP antibodies were used to control for protein expression and
loading. Band intensities were quantified in triplicate to yield the ratios described in the text. Dark
lines separate blots and lighter lines separate lanes cropped from the image of the same blot without
other manipulation.
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C889U INHIBITS TAGGING AT A CLUSTER OF RARE ARG CODONS
We also tested the mutants at other stalling sequences to determine which step in the
stalling and tagging process is defective. We initially anticipated that the bar-P selection might
yield 23S mutants that restore efficient termination at the sequence Pro-opal. If the C889U
mutant acts in this manner, tagging should be inhibited only at Pro-opal and not when ribosomes
are stalled for another reason, such as a string of rare Arg codons. We tested this hypothesis by
inducing stalling at the C-terminus of MBP with eight rare Arg codons (AGG), measuring
tagging in cells containing either wild-type or mutant rRNA. Tagging was dramatically reduced
in the C889U and C889U / U846C mutants compared to the wild-type and H38Δ22 rRNAs
(Figure 2-3). Since the inhibition of tagging is not specific to Pro-opal, it seems unlikely that the
C889U mutant acts by increasing termination efficiency, which presumably is not relevant to
stalling and tagging on the eight-Arg sequence. We were unable to test the 16S A1150Δ mutant
with the eight-Arg MBP construct as its growth was severely inhibited. This increased
sensitivity to Arg-tRNA depletion and ribosome stalling is consistent with a defect in the rescue
process in the A1150Δ strain.

A1150Δ GLOBALLY INHIBITS TM RNA FUNCTION WHEREAS C889U DOES NOT
Since the C889U mutation inhibits tagging at both Pro-opal and a string of rare Arg
codons—unrelated stalling sequences—it could be that it globally inhibits all tmRNA function.
This would occur if the mutation prevents the ribosome from interacting productively with
tmRNA or its associated protein, SmpB. To test this possibility, we measured tagging levels on
constructs which stall at a non-stop mRNA. The trpA transcriptional terminator was cloned
following the full-length MBP gene, creating an mRNA of defined length that lacks a stop
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codon. Analyzing tagging at non-stop mRNAs allows us to study the trans-translation process
alone, apart from stalling and other upstream events.
Analysis with anti-His6 antibodies shows no loss of tagging in either the C889U or the
C889U / U846C mutants on the non-stop construct (Figure 2-3). In contrast, tagging in the
A1150Δ mutant is decreased roughly three-fold versus the wild-type strain. This level of
reduction is similar to that seen with Arg-opal. We conclude that the A1150Δ mutant in 16S
inhibits tmRNA function directly, while the selected 23S mutations do not inhibit the tagging
process itself but some upstream step.

THE C889U MUTATION DOES NOT INDUCE RECODING EVENTS
The C889U mutation reduces tagging at two different stalling sequences (Pro-opal and
eight-Arg) but does not inhibit tmRNA activity itself on a non-stop mRNA. One explanation of
these results could be that it induces higher levels of recoding events. Stalled ribosomes can
shift reading frame or read through stop codons, incorporating a suppressor tRNA. High levels
of +1 frameshifting have been reported at the Pro-opal sequence CCC-UGA62, 63. Recoding is an
attractive explanation because it is downstream of stalling (i.e. slower than efficient
termination) and upstream of tagging. Furthermore, deletion of the A-site finger is reported to
cause an increase in +1 frameshifting levels59.
To test this hypothesis, we measured readthrough and frameshifting levels for ribosomes
stalled at Pro-opal on the full-length GST protein. A sequence encoding the FLAG epitope was
cloned downstream of the stop codon so that the GST-FLAG fusion protein is synthesized if and
only if a recoding event occurs. Three constructs were created: one tests stop codon
readthrough, another tests +1 frameshifting, and the last –1 frameshifting (Figure 2-4A).
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Synthesis of the GST-FLAG fusion was detected by anti-FLAG antibodies on protein extracted
from SQ171 cells expressing either wild-type or C889U mutant rRNAs.
As expected, the sequence CCC-UGA led to very high levels of +1 frameshifting. –1
frameshifting is at a far lower level and readthrough is barely detectable when analyzed on the
same blot at the same intensity (Figure 2-4B, bottom). When each recoding event is analyzed
separately, we clearly see no significant changes in the level of readthrough or in the levels of +1
or –1 frameshifting in the C889U mutant strain. These results show that the reduction in tagging
in the C889U mutant strain is not a result of an increase in recoding events.
Figure 2-4. Analysis of recoding events at Pro-opal

Figure 2-4. ANALYSIS OF RECODING EVENTS AT PRO-OPAL
A) The FLAG epitope was cloned after the stop codon in the GST-Pro-opal construct so that synthesis
of the GST-FLAG fusion depends on readthrough, +1 frameshifting, or –1 frameshifting. B) Recoding
events in SQ171 cells expressing wild-type or C889U rRNA were detected by immunoblot with antiFLAG antibodies. The lower data are from a single blot at a single intensity, illustrating the relative
levels of the three events.
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DISCUSSION
To study ribosome stalling and rescue in E. coli, we created genetic selections that tie
tmRNA activity to cell death. Stalling on a truncated barnase gene leads to rescue by a modified
tmRNA and completion of the toxic protein. Stalling in the bar-R selection is induced by a rare
Arg codon, while stalling in the bar-P selection is induced by inefficient termination at Pro-opal.
These selections are powerful tools for identifying mutations in the translation machinery that
prevent tmRNA function. In principle, they could also be used to identify small molecules that
inhibit trans-translation. This would be of interest because the reduction of tmRNA activity
sensitizes bacteria to antibiotics that target the ribosome64.
We identified three separate 16S rRNA mutants that survive the bar-R selection: A1150G
and deletion of either A1150 or U1123. The A1150 mutation inhibits tmRNA function not only
at the Arg-opal sequence at which it was selected, but also on a non-stop mRNA. We conclude
that this mutation interferes with tmRNA function directly, inhibiting the trans-translation
process itself rather than an upstream step. All three likely work via the same mechanism; they
map to a single site within helix 39 of 16S rRNA (Figure 2-5, right). Despite their distance in
primary sequence, A1150 base pairs with U1123. These mutations are expected to destabilize
pairing in the first stem of helix 39 near this base pair. Helix 39 forms a coaxial stack with
helices 38, 36, and 35, stretching the whole length of the head of the 30S subunit 65. The S9 and
S10 proteins bind helix 39; replacement of the A1152 phosphate with phosphorthioate inhibits
70S ribosome assembly66, presumably because it interferes with proper S10 binding. It seems
possible, then, that these mutations alter the conformation or dynamics of the head of the 30S
subunit.
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Figrue 2-5. Location of the selected rRNA mutants within the ribosome structure2

Figrue 2-5. LOCATION OF THE SELECTED RRNA MUTANTS WITHIN THE RIBOSOME STRUCTURE2
Left: the U846C and C889U mutations lie within helix 38 of 23S rRNA. Helix 38, also known as the Asite finger (dark blue), lies in the central protuberance of the 50S subunit (light blue) and crosses over
the A site where it binds to the S13 protein (red) in the head of the 30S subunit (yellow), forming
intersubunit bridge B1a. Right: the A1150Δ mutation lies within helix 39 of 16S rRNA, as do the
A1150G and U1123Δ mutations identified in the bar-R selection. Helix 39 (orange) lies between the S9
and S10 proteins (black) at the top of the head of the 30S subunit (shown from the cytoplasmic side).
Rendered with Chimera.

We likewise isolated two 23S rRNA clones, C889U alone or in combination with U846C,
that survive the bar-P selection and reduce tagging at Pro-opal. As shown in Figure 5, these
mutations are found in helix 38, the A-site finger (ASF), so called because it contacts the A-site
bound tRNA57, 67. The ASF interacts with the S13 protein in the small subunit to form
intersubunit bridge B1a58. The B1 bridges (B1a, b, and c) are the sole link between the head
substructure in the 30S subunit and the 50S subunit. During the translation process, the B1a
interaction is broken and the ASF changes its binding partner from S13 to S1968. This motion is
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part of the ratchet-like rotation of the head that occurs during translocation upon EF-G binding68.
The fact that the ASF binds A-site tRNA and plays a role in ribosome conformational dynamics
may explain the role of C889U in ribosome stalling and rescue.
The C889U mutation lies immediately next to the nucleotides 886-888 in the loop of the
ASF which interact with S1358. We hypothesized that the C889U mutation might exert its
effects by disrupting the B1a interaction. In support of this idea, deletion of 22 nt at the tip of
helix 38 was reported to reduce the energetic barrier to translocation59. We found, however, that
this H38Δ22 mutant does not lead to survival in the barnase assay nor does it lower tagging
levels in the Pro-opal or at a string of rare Arg codons in the immunoblot assay. If changes in
B1a are responsible for the reduction in tagging, it must be more subtle than mere disruption,
perhaps favoring one ratchet rotation state over the other (S13 / S19). All in all, it seems that
B1a plays a minor role in the normal translation process, since ASF truncations and S13
mutations have only minor effects59-61, 69.
The ASF has a kink-turn motif near its base that is predicted to play a role in its
flexibility and motion70. As the U846C mutation lies within this kink-turn motif, it is tempting to
speculate that it affects the structural dynamics of the ASF. The U846C mutant was only
identified together with C889U, however, and the single and double mutants do not show any
detectable difference in activity in either the immunoblot assays or barnase selection. It is
therefore unclear if this mutation conveys any additional advantage.
How does C889U reduce tagging? It is unlikely that C889U restores high-efficiency
termination, thereby reducing stalling. Two findings support this conclusion. First, although the
C889U mutant was selected for its ability to inhibit tagging at Pro-opal, immunoblots show that
it also reduces tagging levels at a cluster of eight rare Arg codons. While we have not directly
33

ruled out that stalling is reduced at Pro-opal, it seems more likely that a step downstream of
stalling is inhibited, explaining both the Pro-opal and eight-Arg results. Secondly, if termination
rates increased, the level of readthrough and frameshifting should decrease in the mutant strain,
since these recoding events occur because of inefficient termination. We found, however, that
C889U does not alter readthrough or frameshifting levels.
In contrast to the A1150Δ case, the C889U mutant does not inhibit trans-translation itself.
Since neither stalling nor tmRNA function appears to be inhibited in the C889U mutant, it seems
that some intermediate step between the two must be affected. One possibility is that this
mutation may affect processing of the stalled mRNA. Before tmRNA and SmpB can enter the A
site of stalled ribosomes, the downstream mRNA must be removed, either by an A-site
endonuclease or by the action of 3’-5’ exonucleases71. mRNA sequences longer than 12 nt
downstream of the stalled P site prevent rapid release of ribosomes by tmRNA72. An effect on
mRNA processing is an appealing explanation because tagging is reduced only when stalling
occurs in the middle, not at the 3’-end, of an mRNA. We are currently characterizing of the
molecular mechanism of action of the C889U and A1150Δ mutants. Determining the effects of
these mutations will shed light on how the ribosome interacts with tmRNA and SmpB to bring
about the rescue of stalled ribosomes.
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